MedTrace Logo

Safety and Initial Performance of the MediSieve Magnetic Haemofiltration System

NCT03786536 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-11-18

No results posted yet for this study

Summary

This is a single centre, prospective, non-randomised healthy volunteer study to be undertaken at University College Hospital London.

The study will be used to demonstrate the safe use of the MediSieve blood filtration system in healthy volunteers prior to undertaking clinical trials on patients with relevant pathologies.

Conditions

  • Haemofiltration

Interventions

DEVICE

MediSieve Magnetic Haemofiltration System

The MediSieve Magnetic Haemofiltration System is a medical device intended for use in extracorporeal clinical procedures to remove magnetic targets (e.g. malaria infected red blood cells) from a patient's bloodstream.

Sponsors & Collaborators

  • University College London Hospitals

    collaborator OTHER

  • MediSieve Limited

    lead INDUSTRY

Principal Investigators

  • Cristina Blanco Andujar, PhD · MediSieve Limited

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2020-09-01
Completion
2020-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03786536 on ClinicalTrials.gov